中国的心血管-肾脏-代谢综合征：全国性的警钟。 - Suppr

Cardiovascular-Kidney-Metabolic Syndrome in China: A Nationwide Wake-Up Call.

作者信息

Guo Meihan

机构信息

CardioVascular Institute and Division of Cardiology, Department of Medicine, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA.

出版信息

JACC Asia. 2025 Jul;5(7):911-913. doi: 10.1016/j.jacasi.2025.05.007.

DOI:10.1016/j.jacasi.2025.05.007

PMID:40610124

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12277194/

Abstract

摘要

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d42d/12277194/664d10bd4f35/ga1.jpg

相似文献

Cardiovascular-Kidney-Metabolic Syndrome in China: A Nationwide Wake-Up Call.

JACC Asia. 2025 Jul;5(7):911-913. doi: 10.1016/j.jacasi.2025.05.007.

C-reactive protein-triglyceride glucose index in evaluating cardiovascular disease and all-cause mortality incidence among individuals across stages 0-3 of cardiovascular-kidney-metabolic syndrome: a nationwide prospective cohort study.

Cardiovasc Diabetol. 2025 Jul 22;24(1):296. doi: 10.1186/s12933-025-02848-9.

Prevalence and Mortality of Cardiovascular-Kidney-Metabolic Syndrome in China: A Nationwide Population-Based Study.

JACC Asia. 2025 Jul;5(7):898-910. doi: 10.1016/j.jacasi.2025.04.007. Epub 2025 Jun 10.

Cardiovascular-kidney-metabolic syndrome and all-cause and cardiovascular mortality: A retrospective cohort study.

PLoS Med. 2025 Jun 26;22(6):e1004629. doi: 10.1371/journal.pmed.1004629. eCollection 2025 Jun.

Sex Differences in Cardiovascular-Kidney-Metabolic Syndrome: 30-Year US Trends and Mortality Risks-Brief Report.

Arterioscler Thromb Vasc Biol. 2025 Jan;45(1):157-161. doi: 10.1161/ATVBAHA.124.321629. Epub 2024 Dec 12.

Hepatic Steatosis in Cardiovascular-Kidney-Metabolic Syndrome: Fatty Liver Index as a Predictor of Cardiovascular Outcomes.

Eur J Prev Cardiol. 2025 Jun 30. doi: 10.1093/eurjpc/zwaf396.

Rising incidence and clinical impact of kidney cancer in China and worldwide: a call for targeted prevention, early diagnosis, and equitable treatment.

Transl Androl Urol. 2025 May 30;14(5):1391-1407. doi: 10.21037/tau-2024-750. Epub 2025 May 27.

Long-term air pollution exposure and cardiovascular disease risk across cardiovascular-renal-metabolic stages: a nationwide study.

BMC Public Health. 2025 Jul 2;25(1):2179. doi: 10.1186/s12889-025-23348-1.

Semaglutide: a key medication for managing cardiovascular-kidney-metabolic syndrome.

Future Cardiol. 2025 Jul;21(9):663-683. doi: 10.1080/14796678.2025.2511412. Epub 2025 Jun 3.

Triglyceride-glucose-related indices and risk of cardiovascular disease and mortality in individuals with cardiovascular-kidney-metabolic (CKM) syndrome stages 0-3: a prospective cohort study of 282,920 participants in the UK Biobank.

Cardiovasc Diabetol. 2025 Jul 10;24(1):277. doi: 10.1186/s12933-025-02842-1.

本文引用的文献

Prevalence and Mortality of Cardiovascular-Kidney-Metabolic Syndrome in China: A Nationwide Population-Based Study.

JACC Asia. 2025 Jul;5(7):898-910. doi: 10.1016/j.jacasi.2025.04.007. Epub 2025 Jun 10.

Life's Essential 8 cardiovascular health, cardiovascular-kidney-metabolic syndrome stages, and incident cardiovascular events: a nationwide 10-year prospective cohort study in China.

Cardiovasc Diabetol. 2025 May 9;24(1):197. doi: 10.1186/s12933-025-02735-3.

Prevalence of the Cardiovascular-Kidney-Metabolic Syndrome in 3 Chinese Cohorts.

JACC Asia. 2025 Jan 7;5(1):116-118. doi: 10.1016/j.jacasi.2024.10.016. eCollection 2025 Jan.

Prevalence of Cardiovascular-Kidney-Metabolic Syndrome Stages by Social Determinants of Health.

JAMA Netw Open. 2024 Nov 4;7(11):e2445309. doi: 10.1001/jamanetworkopen.2024.45309.

Cardiovascular-Kidney-Metabolic Syndrome Among Healthcare Workers in Chinese Tertiary Hospital.

Risk Manag Healthc Policy. 2024 Nov 2;17:2647-2657. doi: 10.2147/RMHP.S488289. eCollection 2024.

National burden and risk factors of diabetes mellitus in China from 1990 to 2021: Results from the Global Burden of Disease study 2021.

J Diabetes. 2024 Oct;16(10):e70012. doi: 10.1111/1753-0407.70012.

Association between different stages of cardiovascular-kidney-metabolic syndrome and the risk of all-cause mortality.

Atherosclerosis. 2024 Oct;397:118585. doi: 10.1016/j.atherosclerosis.2024.118585. Epub 2024 Aug 30.

Cardiovascular-Kidney-Metabolic Health: A Presidential Advisory From the American Heart Association.

Circulation. 2023 Nov 14;148(20):1606-1635. doi: 10.1161/CIR.0000000000001184. Epub 2023 Oct 9.

A Synopsis of the Evidence for the Science and Clinical Management of Cardiovascular-Kidney-Metabolic (CKM) Syndrome: A Scientific Statement From the American Heart Association.

Circulation. 2023 Nov 14;148(20):1636-1664. doi: 10.1161/CIR.0000000000001186. Epub 2023 Oct 9.

Report on cardiovascular health and diseases in China 2021: an updated summary.

J Geriatr Cardiol. 2023 Jun 28;20(6):399-430. doi: 10.26599/1671-5411.2023.06.001.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Cardiovascular-Kidney-Metabolic Syndrome in China: A Nationwide Wake-Up Call.

作者信息

Guo Meihan

机构信息

CardioVascular Institute and Division of Cardiology, Department of Medicine, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA.

出版信息

JACC Asia. 2025 Jul;5(7):911-913. doi: 10.1016/j.jacasi.2025.05.007.

DOI:10.1016/j.jacasi.2025.05.007

PMID:40610124

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12277194/

Abstract

摘要

相似文献

Cardiovascular-Kidney-Metabolic Syndrome in China: A Nationwide Wake-Up Call.

JACC Asia. 2025 Jul;5(7):911-913. doi: 10.1016/j.jacasi.2025.05.007.

Cardiovasc Diabetol. 2025 Jul 22;24(1):296. doi: 10.1186/s12933-025-02848-9.

Prevalence and Mortality of Cardiovascular-Kidney-Metabolic Syndrome in China: A Nationwide Population-Based Study.

JACC Asia. 2025 Jul;5(7):898-910. doi: 10.1016/j.jacasi.2025.04.007. Epub 2025 Jun 10.

Cardiovascular-kidney-metabolic syndrome and all-cause and cardiovascular mortality: A retrospective cohort study.

PLoS Med. 2025 Jun 26;22(6):e1004629. doi: 10.1371/journal.pmed.1004629. eCollection 2025 Jun.

Sex Differences in Cardiovascular-Kidney-Metabolic Syndrome: 30-Year US Trends and Mortality Risks-Brief Report.

Arterioscler Thromb Vasc Biol. 2025 Jan;45(1):157-161. doi: 10.1161/ATVBAHA.124.321629. Epub 2024 Dec 12.

Hepatic Steatosis in Cardiovascular-Kidney-Metabolic Syndrome: Fatty Liver Index as a Predictor of Cardiovascular Outcomes.

Eur J Prev Cardiol. 2025 Jun 30. doi: 10.1093/eurjpc/zwaf396.

Rising incidence and clinical impact of kidney cancer in China and worldwide: a call for targeted prevention, early diagnosis, and equitable treatment.

Transl Androl Urol. 2025 May 30;14(5):1391-1407. doi: 10.21037/tau-2024-750. Epub 2025 May 27.

Long-term air pollution exposure and cardiovascular disease risk across cardiovascular-renal-metabolic stages: a nationwide study.

BMC Public Health. 2025 Jul 2;25(1):2179. doi: 10.1186/s12889-025-23348-1.

Semaglutide: a key medication for managing cardiovascular-kidney-metabolic syndrome.

Future Cardiol. 2025 Jul;21(9):663-683. doi: 10.1080/14796678.2025.2511412. Epub 2025 Jun 3.

Cardiovasc Diabetol. 2025 Jul 10;24(1):277. doi: 10.1186/s12933-025-02842-1.

本文引用的文献

Prevalence and Mortality of Cardiovascular-Kidney-Metabolic Syndrome in China: A Nationwide Population-Based Study.

JACC Asia. 2025 Jul;5(7):898-910. doi: 10.1016/j.jacasi.2025.04.007. Epub 2025 Jun 10.

Life's Essential 8 cardiovascular health, cardiovascular-kidney-metabolic syndrome stages, and incident cardiovascular events: a nationwide 10-year prospective cohort study in China.

Cardiovasc Diabetol. 2025 May 9;24(1):197. doi: 10.1186/s12933-025-02735-3.

Prevalence of the Cardiovascular-Kidney-Metabolic Syndrome in 3 Chinese Cohorts.

JACC Asia. 2025 Jan 7;5(1):116-118. doi: 10.1016/j.jacasi.2024.10.016. eCollection 2025 Jan.

Prevalence of Cardiovascular-Kidney-Metabolic Syndrome Stages by Social Determinants of Health.

JAMA Netw Open. 2024 Nov 4;7(11):e2445309. doi: 10.1001/jamanetworkopen.2024.45309.

Cardiovascular-Kidney-Metabolic Syndrome Among Healthcare Workers in Chinese Tertiary Hospital.

Risk Manag Healthc Policy. 2024 Nov 2;17:2647-2657. doi: 10.2147/RMHP.S488289. eCollection 2024.

National burden and risk factors of diabetes mellitus in China from 1990 to 2021: Results from the Global Burden of Disease study 2021.

J Diabetes. 2024 Oct;16(10):e70012. doi: 10.1111/1753-0407.70012.

Association between different stages of cardiovascular-kidney-metabolic syndrome and the risk of all-cause mortality.

Atherosclerosis. 2024 Oct;397:118585. doi: 10.1016/j.atherosclerosis.2024.118585. Epub 2024 Aug 30.

Cardiovascular-Kidney-Metabolic Health: A Presidential Advisory From the American Heart Association.

Circulation. 2023 Nov 14;148(20):1606-1635. doi: 10.1161/CIR.0000000000001184. Epub 2023 Oct 9.

A Synopsis of the Evidence for the Science and Clinical Management of Cardiovascular-Kidney-Metabolic (CKM) Syndrome: A Scientific Statement From the American Heart Association.

Circulation. 2023 Nov 14;148(20):1636-1664. doi: 10.1161/CIR.0000000000001186. Epub 2023 Oct 9.

Report on cardiovascular health and diseases in China 2021: an updated summary.

J Geriatr Cardiol. 2023 Jun 28;20(6):399-430. doi: 10.26599/1671-5411.2023.06.001.

Cardiovascular-Kidney-Metabolic Syndrome in China: A Nationwide Wake-Up Call.

作者信息

机构信息

出版信息

相似文献

本文引用的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

Cardiovascular-Kidney-Metabolic Syndrome in China: A Nationwide Wake-Up Call.

作者信息

机构信息

出版信息

相似文献

本文引用的文献